CEL-SCI Corp. (CVM)
1.38
-0.12
(-8.00%)
USD |
NYAM |
Oct 30, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
CEL-SCI Price to Book Value : 2.216 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.216 |
| October 29, 2026 | 2.408 |
| October 28, 2026 | 2.569 |
| October 27, 2026 | 2.520 |
| October 26, 2026 | 2.553 |
| October 23, 2026 | 2.633 |
| October 22, 2026 | 2.585 |
| October 21, 2026 | 2.601 |
| October 20, 2026 | 2.488 |
| October 19, 2026 | 2.649 |
| October 16, 2026 | 2.874 |
| October 15, 2026 | 2.793 |
| October 14, 2026 | 2.745 |
| October 13, 2026 | 2.810 |
| October 12, 2026 | 2.938 |
| October 09, 2026 | 3.114 |
| October 08, 2026 | 3.131 |
| October 07, 2026 | 3.420 |
| October 06, 2026 | 4.399 |
| October 05, 2026 | 3.885 |
| October 02, 2026 | 3.708 |
| October 01, 2026 | 3.355 |
| September 30, 2026 | 3.307 |
| September 29, 2026 | 2.874 |
| September 28, 2026 | 2.729 |
| Date | Value |
|---|---|
| September 25, 2026 | 2.681 |
| September 24, 2026 | 2.761 |
| September 23, 2026 | 2.697 |
| September 22, 2026 | 2.729 |
| September 21, 2026 | 2.681 |
| September 18, 2026 | 2.665 |
| September 17, 2026 | 2.392 |
| September 16, 2026 | 2.376 |
| September 15, 2026 | 2.376 |
| September 14, 2026 | 2.440 |
| September 11, 2026 | 2.392 |
| September 10, 2026 | 2.440 |
| September 09, 2026 | 2.472 |
| September 08, 2026 | 2.649 |
| September 04, 2026 | 2.617 |
| September 03, 2026 | 2.585 |
| September 02, 2026 | 2.649 |
| September 01, 2026 | 2.585 |
| August 31, 2026 | 2.601 |
| August 28, 2026 | 2.504 |
| August 27, 2026 | 2.569 |
| August 26, 2026 | 2.585 |
| August 25, 2026 | 2.376 |
| August 24, 2026 | 2.216 |
| August 21, 2026 | 2.280 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.55 |
| Anika Therapeutics, Inc. | 2.042 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.014 |
Price to Book Value Related Metrics
| Price | 1.38 |
| Earnings Yield | -187.2% |
| Market Cap | 24.27M |